Cargando…

The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment

BACKGROUND: A number of naturalistic studies have investigated paliperidone palmitate (PP) using proxy measures of effectiveness. An unexplored option is to examine the utility of the mental health clustering tool (MHCT), which is used in UK clinical practice to measure patient well-being and is lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tompsett, Tamara, Masters, Kate, Donyai, Parastou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841343/ https://www.ncbi.nlm.nih.gov/pubmed/29535524 http://dx.doi.org/10.2147/NDT.S151174

Ejemplares similares

Intentions to “Reuse” Medication in the Future Modelled and Measured Using the Theory of Planned Behavior
por: Alhamad, Hamza, et al.
Publicado: (2020)

The Development of Schematics to Illustrate Women’s Experiences with Adjuvant Hormone Therapy in the Treatment of Breast Cancer
por: AlOmeir, Othman, et al.
Publicado: (2022)

Development and utilization of the Medicines Use Review patient satisfaction questionnaire
por: Hindi, Ali, et al.
Publicado: (2017)

What stops practitioners discussing medication breaks in children and adolescents with ADHD? Identifying barriers through theory-driven qualitative research
por: Ibrahim, Kinda, et al.
Publicado: (2018)

Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence
por: Kelin, Katarina, et al.
Publicado: (2011)

The cooccurrence of heightened media attention and adverse drug reaction reports for hormonal contraception in the United Kingdom between 2014 and 2017
por: Postma, Lobke Geesje Maria, et al.
Publicado: (2020)

News Media Coverage of the Problem of Purchasing Fake Prescription Medicines on the Internet: Thematic Analysis
por: Almomani, Hamzeh, et al.
Publicado: (2023)

Reasons That Lead People to End Up Buying Fake Medicines on the Internet: Qualitative Interview Study
por: Almomani, Hamzeh, et al.
Publicado: (2023)

The Validity of the Theory of Planned Behaviour for Understanding People’s Beliefs and Intentions toward Reusing Medicines
por: Alhamad, Hamza, et al.
Publicado: (2021)

How do people conceptualise the reuse of medicines? An interview study
por: Alhamad, Hamza, et al.
Publicado: (2017)

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Knowledge, Attitude and Advice-Giving Behaviour of Community Pharmacists Regarding Topical Corticosteroids
por: Lau, Wing Man, et al.
Publicado: (2017)

Hobson’s choice or a horned dilemma: a grounded theory on adherence to adjuvant endocrine therapy verified with breast cancer survivors
por: AlOmeir, Othman, et al.
Publicado: (2022)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Towards Medicines Reuse: A Narrative Review of the Different Therapeutic Classes and Dosage Forms of Medication Waste in Different Countries
por: Alhamad, Hamza, et al.
Publicado: (2020)

A phenomenological analysis of the experience of taking medication to prevent a further heart attack
por: Piekarz, Hannah, et al.
Publicado: (2021)

Exploring Drug Shortages in the United Kingdom
por: Obiedalla, Mohamed, et al.
Publicado: (2023)

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
por: Nakagawa, Ryoko, et al.
Publicado: (2015)

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan
por: Ye, Wenyu, et al.
Publicado: (2011)

Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory
por: AlOmeir, Othman, et al.
Publicado: (2020)

Community Pharmacy and COVID-19—The Unsung Heroes on Our High Streets
por: Parkhurst, Caroline, et al.
Publicado: (2020)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2006)

The Construction and Validation of Child, Adolescent and Parental Decision Aids for Considering Methylphenidate Drug Holidays in ADHD
por: Ibrahim, Kinda, et al.
Publicado: (2018)

Medication-taking for secondary prevention of acute myocardial infarction: a thematic meta-synthesis of patient experiences
por: Piekarz, Hannah, et al.
Publicado: (2022)

Reasons that lead people to buy prescription medicines on the internet: a systematic review
por: Almomani, Hamzeh, et al.
Publicado: (2023)

Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
por: Buoli, Massimiliano, et al.
Publicado: (2012)

A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2004)

One-year Outcome of First vs. Later Episode Schizophrenia: A Real-world Naturalistic Study
por: Fountoulakis, Konstantinos N., et al.
Publicado: (2020)

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes
por: Raza, Amna, et al.
Publicado: (2023)

Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes
por: Chen, Chia-Hui, et al.
Publicado: (2012)

Do antipsychotics limit disability in schizophrenia? A naturalistic comparative study in the community
por: Thirthalli, Jagadisha, et al.
Publicado: (2010)

Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations
por: Rossi, Giuseppe, et al.
Publicado: (2012)

Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population
por: Janno, Sven, et al.
Publicado: (2005)

Cost Utility of cognition-enhancing interventions for individuals with first-episode psychosis: a naturalistic evaluation
por: Breitborde, Nicholas J. K., et al.
Publicado: (2021)

Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
por: Bove, Riley, et al.
Publicado: (2015)

Enabling Medicine Reuse Using a Digital Time Temperature Humidity Sensor in an Internet of Pharmaceutical Things Concept
por: Hui, Terence K. L., et al.
Publicado: (2020)

Stakeholder Views on the Idea of Medicines Reuse in the UK
por: Donyai, Parastou, et al.
Publicado: (2021)

Atypical Antipsychotics in the Treatment of Depressive and Psychotic Symptoms in Patients with Chronic Schizophrenia: A Naturalistic Study
por: Innamorati, Marco, et al.
Publicado: (2013)

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan
por: Ye, Wenyu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2qhrebfmclp1kl3uq04d644g47